Artificial Intelligence (AI) technology is set to revolutionize the diagnosis of hepatocellular carcinoma (HCC), the most common form of liver cancer. AI models are capable of analyzing large volumes of imaging data with high precision, enabling early detection of the disease. This breakthrough promises to reduce diagnostic variability, streamline data analysis, and optimize the allocation of healthcare resources. Early detection of HCC is critical as curative treatments are only viable during the initial stages of the disease, leading to increased survival rates and reduced healthcare costs.